Study Published in Journal of Clinical Investigation Insight Demonstrates Ability to Predict Early Rejection in Kidney Transplant with FractalDx Portfolio Technology

Positive study results support successful development of a predictive blood test for transplant patients to meet critical unmet medical need NEW YORK, June 7, 2019 -- (Healthcare Sales & Marketing Network) -- Renalytix AI plc (AIM: RENX), a developer o... Diagnostics RenalytixAI, FractalDx, transplant rejection
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news